Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
More than 250,000 people living with HIV would be affected by a proposed rule change to Medicare Part D.
Periodic infusions of long-acting HIV antibodies may eventually become a new way of treating the virus.
Today, with better understanding of the complex task at hand, cure researchers are investigating multiple avenues and taking the long view.
In a move to cut Medicare costs, the proposed changes would also affect people with cancer, depression and schizophrenia.
Today’s HIV meds are not linked to this common condition.
Charles Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF), analyzes data from a 2018 UNAIDS report.
The Impact of Hurricane Maria on HIV
The single-tablet antiretroviral regimen includes Janssen’s darunavir plus Gilead’s cobicistat, emtricitabine and tenofovir alafenamide.
AVR treatment halts brain damage and reduces damage.
Gene editing in monkeys creates SHIV-resistant immune cells.
Whites have a higher rate of successful HIV treatment.
Research found that healthcare providers could do better at preventing drug interactions.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.